Recall batches of SABRIL 500MG F.C.TAB
2024-02-28
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer SABRIL 500MG F.C.TAB Vigabatrin 500 Mg 25-883-19 2006B 2988D 2989A 2990D sanofi-aventis
<p><span><span><span>Saudi FDA issued Recall four batches of</span> <span>SABRIL 500MG F.C.TAB due to) Tiapride (cross Contamination. Sanofi-Aventis is voluntarily recalling the affected batches.</span></span></span></p>
<p><span><span><strong><span>For healthcare professionals, </span></strong><span>Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.</span></span></span></p>
<p><span><span><strong><span>For patients,</span></strong></span></span></p>
<ul>
<li><span><span><span><span>Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.</span></span></span></span></li>
<li><span><span><span><span>Contact the recalling firm or Saudi FDA if you have any questions about the recall.</span></span></span></span></li>
<li><span><span><span><span>Adverse reactions or quality problems experienced with the use of this product may be reported to </span><a href="https://ade.sfda.gov.sa/"><span>Saudi Vigilance</span></a><span> either online or call center (Call 19999).</span></span></span></span></li>
</ul>
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.